​

Gain Therapeutics (GANX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Gain Therapeutics Revenue Highlights

00

Gain Therapeutics Revenue by Period

Gain Therapeutics Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$55.18K-60.62%
2022-12-31$140.11K-15.08%
2021-12-31$164.99K471.29%
2020-12-31$28.88K-30.07%
2019-12-31$41.30K100.40%
2018-12-31$20.61K-

Gain Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Gain Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$82.24K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$64.80K100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$55.18K-60.62%
2022-12-31$140.11K100.00%
2022-09-30--100.00%
2022-06-30$95.10K153.35%
2022-03-31$37.54K3.29%
2021-12-31$36.34K127.54%
2021-09-30$15.97K-80.43%
2021-06-30$81.62K1449.00%
2021-03-31$5.27K-42.35%
2020-12-31$9.14K36.48%
2020-09-30$6.70K5.07%
2020-06-30$6.37K-4.50%
2020-03-31$6.67K100.00%
2019-12-31--100.00%
2019-09-30$10.32K-
2019-06-30$10.32K-
2019-03-31$10.32K100.41%
2018-09-30$5.15K-
2018-06-30$5.15K-
2018-03-31$5.15K-

Gain Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Gain Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FBIOFortress Biotech$55.13M$17.02M
ADAGAdagene$18.11M$833.34K
TCRXTScan Therapeutics$2.82M-
NTRBNutriband$2.14M$622.45K
OSTXOS Therapies--
CRVOCervoMed--
ACETAdicet Bio--
NRXPNRx Pharmaceuticals-$242.00K
XBITXBiotech--
GANXGain Therapeutics--
LITSLite Strategy--

GANX Revenue FAQ

What is Gain Therapeutics’s yearly revenue?

Gain Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $55.18K, representing a decrease of -60.62% compared to 2022. GANX's yearly revenue for 2022 was $140.11K, representing a decrease of -15.08% compared to 2021.

What is Gain Therapeutics’s quarterly revenue?

Gain Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). GANX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Gain Therapeutics’s revenue growth rate?

Gain Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.